1. Home
  2. FTF vs CERS Comparison

FTF vs CERS Comparison

Compare FTF & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Limited Duration Income Trust of Beneficial Interest

FTF

Franklin Limited Duration Income Trust of Beneficial Interest

HOLD

Current Price

$6.11

Market Cap

256.6M

Sector

Finance

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$1.77

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTF
CERS
Founded
2003
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
256.6M
276.0M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
FTF
CERS
Price
$6.11
$1.77
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
153.9K
1.3M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
11.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$199,191,000.00
Revenue This Year
N/A
$19.07
Revenue Next Year
N/A
$12.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.03
52 Week Low
$5.76
$1.12
52 Week High
$6.56
$2.24

Technical Indicators

Market Signals
Indicator
FTF
CERS
Relative Strength Index (RSI) 48.07 62.33
Support Level $5.96 $1.47
Resistance Level $6.17 $1.78
Average True Range (ATR) 0.04 0.11
MACD 0.01 0.02
Stochastic Oscillator 70.73 95.16

Price Performance

Historical Comparison
FTF
CERS

About FTF Franklin Limited Duration Income Trust of Beneficial Interest

Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: